Paragon Associates & Paragon Associates Ii Joint Venture
Latest statistics and disclosures from Paragon Associates & Paragon Associates Ii Joint Venture's latest quarterly 13F-HR filing:
- Top 5 stock holdings are NVGS, AEM, NEM, EPSN, BELFB, and represent 71.55% of Paragon Associates & Paragon Associates Ii Joint Venture's stock portfolio.
- Added to shares of these 3 stocks: NEM, AKYA, FNV.
- Started 1 new stock position in AKYA.
- Reduced shares in these 10 stocks: , , AEM, UBS, BP, NVGS, HUM, ECVT, BELFB, GEL.
- Sold out of its positions in BP, GEL, HUM, PBF, VLO, UBS.
- Paragon Associates & Paragon Associates Ii Joint Venture was a net seller of stock by $-17M.
- Paragon Associates & Paragon Associates Ii Joint Venture has $41M in assets under management (AUM), dropping by -27.10%.
- Central Index Key (CIK): 0001047859
Tip: Access up to 7 years of quarterly data
Positions held by Paragon Associates & Paragon Associates Ii Joint Venture consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Paragon Associates & Paragon Associates Ii Joint Venture
Paragon Associates & Paragon Associates Ii Joint Venture holds 11 positions in its portfolio as reported in the June 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Navigator Hldgs SHS (NVGS) | 25.6 | $11M | -14% | 600k | 17.46 |
|
| Agnico (AEM) | 14.4 | $5.9M | -40% | 90k | 65.40 |
|
| Newmont Mining Corporation (NEM) | 11.8 | $4.8M | +130% | 115k | 41.87 |
|
| Epsilon Energy (EPSN) | 10.7 | $4.4M | 800k | 5.45 |
|
|
| Bel Fuse CL B (BELFB) | 9.1 | $3.7M | -5% | 57k | 65.24 |
|
| Franco-Nevada Corporation (FNV) | 8.7 | $3.6M | +20% | 30k | 118.52 |
|
| IRIDEX Corporation (IRIX) | 5.3 | $2.2M | 1.0M | 2.16 |
|
|
| Ecovyst (ECVT) | 5.3 | $2.2M | -19% | 240k | 8.97 |
|
| Allison Transmission Hldngs I (ALSN) | 3.7 | $1.5M | 20k | 75.90 |
|
|
| Diamedica Therapeutics Com New (DMAC) | 3.5 | $1.4M | -3% | 483k | 2.95 |
|
| Akoya Biosciences (AKYA) | 2.0 | $819k | NEW | 350k | 2.34 |
|
Past Filings by Paragon Associates & Paragon Associates Ii Joint Venture
SEC 13F filings are viewable for Paragon Associates & Paragon Associates Ii Joint Venture going back to 2013
- Paragon Associates & Paragon Associates Ii Joint Venture 2024 Q2 filed Aug. 13, 2024
- Paragon Associates & Paragon Associates Ii Joint Venture 2024 Q1 filed May 14, 2024
- Paragon Associates & Paragon Associates Ii Joint Venture 2023 Q4 filed Feb. 14, 2024
- Paragon Associates & Paragon Associates Ii Joint Venture 2023 Q3 filed Nov. 14, 2023
- Paragon Associates & Paragon Associates Ii Joint Venture 2023 Q2 filed Aug. 14, 2023
- Paragon Associates & Paragon Associates Ii Joint Venture 2023 Q1 filed May 15, 2023
- Paragon Associates & Paragon Associates Ii Joint Venture 2022 Q4 filed Feb. 13, 2023
- Paragon Associates & Paragon Associates Ii Joint Venture 2022 Q3 filed Nov. 14, 2022
- Paragon Associates & Paragon Associates Ii Joint Venture 2022 Q2 filed Aug. 16, 2022
- Paragon Associates & Paragon Associates Ii Joint Venture 2022 Q1 filed May 16, 2022
- Paragon Associates & Paragon Associates Ii Joint Venture 2021 Q4 filed Feb. 14, 2022
- Paragon Associates & Paragon Associates Ii Joint Venture 2021 Q3 filed Nov. 15, 2021
- Paragon Associates & Paragon Associates Ii Joint Venture 2021 Q2 filed Aug. 16, 2021
- Paragon Associates & Paragon Associates Ii Joint Venture 2021 Q1 filed May 14, 2021
- Paragon Associates & Paragon Associates Ii Joint Venture 2020 Q4 filed Feb. 12, 2021
- Paragon Associates & Paragon Associates Ii Joint Venture 2020 Q3 filed Nov. 13, 2020